Novel Therapeutics in Alzheimer's Disease
نویسندگان
چکیده
1Banner Sun Health Research Institute, 10515 W. Santa Fe Dr, Sun City, AZ 85351, USA 2Alzheimer’s Disease Care, Research and Education Program (AD-CARE) and Memory Disorders Clinic, University of Rochester School of Medicine and Dentistry, 435 East Henrietta Road, Rochester, NY 14620, USA 3Quincy Medical Center and Alzheimer’s Disease Center/Clinical Trials, 114 Whitwell St, Quincy, MA 02169, USA 4Department of Pharmacology & Therapeutics, Faculty of Medicine & Health Sciences, UAE University, Al Ain, UAE
منابع مشابه
Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.
Alzheimer's disease, one of the most important brain pathologies associated with neurodegenerative processes, is related to overactivation of calpain-mediated proteolysis. Previous data showed a compelling efficacy of calpain inhibition against abnormal synaptic plasticity and memory produced by the excess of amyloid-β, a distinctive marker of the disease. Moreover, a beneficial effect of calpa...
متن کاملPulmonary drug delivery: Implication for new strategy for pharmacotherapy for neurodegenerative disorders.
Innovative drug delivery in the treatment of brain neurodegenerative disorders such as Parkinson's disease (PD) and Alzheimer's disease (AD) has the potential to avoid many unwanted side effects over current medications. Advances in understanding of these diseases and their treatments have led to the search for novel modes of drug delivery. In this review, we have highlighted new strategies and...
متن کاملDigital technologies for cognitive assessment to accelerate drug development in Alzheimer's disease
For many neurological and psychiatric diseases, novel therapeutics have been elusive for decades. By focusing on attention interference in Alzheimer's disease (AD), we provide a future vision on how emerging mobile, computer, and device-based cognitive tools are converting classically noisy, subjective, data-poor clinical endpoints associated with neuropsychiatric disease assessment into a rich...
متن کاملDrug repositioning in Alzheimer's disease.
Drug repositioning offers an innovative approach to drug discovery with great potential in the field of Alzheimer's Disease and dementia therapeutics. Investigation of licensed compounds enables processing through the drug discovery pipeline in a rapid and cost-effective manner. A growing body of evidence supports the translation of priority compounds to be taken forward to clinical trials, bas...
متن کاملThe role of genetics in alzheimer’s disease
Alzheimer's disease is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells die. Alzheimer's disease is the most common cause of dementia and causes a decrease in thinking skills and social behaviors. Alzheimer's disease is more common in people over 65 years old. The risk of developing Alzheimer's disease and other types of dementia increases with age,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
دوره 2012 شماره
صفحات -
تاریخ انتشار 2012